View Item 

Show simple item record

Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice
dc.contributor.authorCarpenter, Kristin J.en_US
dc.contributor.authorEwing, Jillian L.en_US
dc.contributor.authorSchuh, Jane M.en_US
dc.contributor.authorNess, Traci L.en_US
dc.contributor.authorKunkel, Steven L.en_US
dc.contributor.authorAparici, Monicaen_US
dc.contributor.authorMiralpeix, Montserraten_US
dc.contributor.authorHogaboam, Cory M.en_US
dc.date.accessioned2010-06-01T18:14:03Z
dc.date.available2010-06-01T18:14:03Z
dc.date.issued2005-08en_US
dc.identifier.citationCarpenter, Kristin J; Ewing, Jillian L; Schuh, Jane M; Ness, Traci L; Kunkel, Steven L; Aparici, Monica; Miralpeix, Montserrat; Hogaboam, Cory M (2005). "Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice." British Journal of Pharmacology 145(8): 1160-1172. <http://hdl.handle.net/2027.42/71445>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71445
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15951834&dopt=citationen_US
dc.format.extent635268 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2005 British Pharmacological Societyen_US
dc.subject.otherChemokineen_US
dc.subject.otherChemokine Receptoren_US
dc.subject.otherCCR1en_US
dc.subject.otherFungal Asthmaen_US
dc.subject.otherBX-471en_US
dc.subject.otherTherapyen_US
dc.subject.otherAspergillus Fumigatusen_US
dc.titleTherapeutic targeting of CCR1 attenuates established chronic fungal asthma in miceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherResearch Centre, Almirall Prodesfarma, Cardener, 68-7408024 Barcelona, Spainen_US
dc.identifier.pmid15951834en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71445/1/sj.bjp.0706243.pdf
dc.identifier.doi10.1038/sj.bjp.0706243en_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceANDERS, H. J., BANAS, B., LINDE, Y., WELLER, L., COHEN, C. D., KRETZLER, M., MARTIN, S., VIELHAUER, V., SCHLONDORFF, D. & GRONE, H. J. ( 2003 ). Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J. Am. Soc. Nephrol., 14, 317 – 326.en_US
dc.identifier.citedreferenceANDERS, H. J., BELEMEZOVA, E., EIS, V., SEGERER, S., VIELHAUER, V., PEREZ DE LEMA, G., KRETZLER, M., COHEN, C. D., FRINK, M., HORUK, R., HUDKINS, K. L., ALPERS, C. E., MAMPASO, F. & SCHLONDORFF, D. ( 2004 ). Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas (lpr) mice. J. Am. Soc. Nephrol., 15, 1504 – 1513.en_US
dc.identifier.citedreferenceANDERS, H. J., VIELHAUER, V., FRINK, M., LINDE, Y., COHEN, C. D., BLATTNER, S. M., KRETZLER, M., STRUTZ, F., MACK, M., GRONE, H. J., ONUFFER, J., HORUK, R., NELSON, P. J. & SCHLONDORFF, D. ( 2002 ). A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest., 109, 251 – 259.en_US
dc.identifier.citedreferenceBACHAR, O., ADNER, M., UDDMAN, R. & CARDELL, L. O. ( 2004 ). Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur. J. Immunol., 34, 1196 – 1207.en_US
dc.identifier.citedreferenceBARNES, P. J. ( 2001 ). Cytokine-directed therapies for asthma. J. Allergy Clin. Immunol., 108, S72 – S76.en_US
dc.identifier.citedreferenceBELLOCCHIO, S., MONTAGNOLI, C., BOZZA, S., GAZIANO, R., ROSSI, G., MAMBULA, S. S., VECCHI, A., MANTOVANI, A., LEVITZ, S. M. & ROMANI, L. ( 2004 ). The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol., 172, 3059 – 3069.en_US
dc.identifier.citedreferenceBLEASE, K., KUNKEL, S. L. & HOGABOAM, C. M. ( 2001a ). IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflamm. Res., 50, 552 – 560.en_US
dc.identifier.citedreferenceBLEASE, K., MEHRAD, B., LUKACS, N. W., KUNKEL, S. L., STANDIFORD, T. J. & HOGABOAM, C. M. ( 2001b ). Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J. Immunol., 166, 1832 – 1842.en_US
dc.identifier.citedreferenceBLEASE, K., MEHRAD, B., STANDIFORD, T. J., LUKACS, N. W., KUNKEL, S. L., CHENSUE, S. W., LU, B., GERARD, C. J. & HOGABOAM, C. M. ( 2000 ). Airway remodeling is absent in CCR1−/− mice during chronic fungal allergic airway disease. J. Immunol., 165, 1564 – 1572.en_US
dc.identifier.citedreferenceCHANTRY, D. & BURGESS, L. E. ( 2002 ). Chemokines in allergy. Curr. Drug Targets Inflamm. Allergy, 1, 109 – 116.en_US
dc.identifier.citedreferenceEDER, W., KLIMECKI, W., YU, L., VON MUTIUS, E., RIEDLER, J., BRAUN-FAHRLANDER, C., NOWAK, D. & MARTINEZ, F. D. ( 2004 ). Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol., 113, 482 – 488.en_US
dc.identifier.citedreferenceEVANOFF, H., BURDICK, M. D., MOORE, S. A., KUNKEL, S. L. & STRIETER, R. M. ( 1992 ). A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest., 21, 39 – 49.en_US
dc.identifier.citedreferenceGRUNIG, G., CORRY, D. B., LEACH, M. W., SEYMOUR, B. W., KURUP, V. P. & RENNICK, D. M. ( 1997 ). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med., 185, 1089 – 1099.en_US
dc.identifier.citedreferenceHALLMAN, M., RAMET, M. & EZEKOWITZ, R. A. ( 2001 ). Toll-like receptors as sensors of pathogens. Pediatr. Res., 50, 315 – 321.en_US
dc.identifier.citedreferenceHAYASHI, T., BECK, L., ROSSETTO, C., GONG, X., TAKIKAWA, O., TAKABAYASHI, K., BROIDE, D. H., CARSON, D. A. & RAZ, E. ( 2004 ). Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest., 114, 270 – 279.en_US
dc.identifier.citedreferenceHESSELGESSER, J., NG, H. P., LIANG, M., ZHENG, W., MAY, K., BAUMAN, J. G., MONAHAN, S., ISLAM, I., WEI, G. P., GHANNAM, A., TAUB, D. D., ROSSER, M., SNIDER, R. M., MORRISSEY, M. M., PEREZ, H. D. & HORUK, R. ( 1998 ). Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J. Biol. Chem., 273, 15687 – 15692.en_US
dc.identifier.citedreferenceHOGABOAM, C. M., BLEASE, K., MEHRAD, B., STEINHAUSER, M. L., STANDIFORD, T. J., KUNKEL, S. L. & LUKACS, N. W. ( 2000 ). Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol., 156, 723 – 732.en_US
dc.identifier.citedreferenceHOGABOAM, C. M., BLEASE, K. & SCHUH, J. M. ( 2003 ). Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental Aspergillus-induced allergic airway or asthmatic disease. Front Biosci., 8, e147 – e156.en_US
dc.identifier.citedreferenceHOGABOAM, C. M., GALLINAT, C. S., TAUB, D. D., STRIETER, R. M., KUNKEL, S. L. & LUKACS, N. W. ( 1999 ). Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J. Immunol., 162, 6071 – 6079.en_US
dc.identifier.citedreferenceHORUK, R., CLAYBERGER, C., KRENSKY, A. M., WANG, Z., GRONE, H. J., WEBER, C., WEBER, K. S., NELSON, P. J., MAY, K., ROSSER, M., DUNNING, L., LIANG, M., BUCKMAN, B., GHANNAM, A., NG, H. P., ISLAM, I., BAUMAN, J. G., WEI, G. P., MONAHAN, S., XU, W., SNIDER, R. M., MORRISSEY, M. M., HESSELGESSER, J. & PEREZ, H. D. ( 2001a ). A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J. Biol. Chem., 276, 4199 – 4204.en_US
dc.identifier.citedreferenceHORUK, R., SHUREY, S., NG, H. P., MAY, K., BAUMAN, J. G., ISLAM, I., GHANNAM, A., BUCKMAN, B., WEI, G. P., XU, W., LIANG, M., ROSSER, M., DUNNING, L., HESSELGESSER, J., SNIDER, R. M., MORRISSEY, M. M., PEREZ, H. D. & GREEN, C. ( 2001b ). CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol. Lett., 76, 193 – 201.en_US
dc.identifier.citedreferenceLIANG, M., MALLARI, C., ROSSER, M., NG, H. P., MAY, K., MONAHAN, S., BAUMAN, J. G., ISLAM, I., GHANNAM, A., BUCKMAN, B., SHAW, K., WEI, G. P., XU, W., ZHAO, Z., HO, E., SHEN, J., OANH, H., SUBRAMANYAM, B., VERGONA, R., TAUB, D., DUNNING, L., HARVEY, S., SNIDER, R. M., HESSELGESSER, J., MORRISSEY, M. M. & PEREZ, H. D. ( 2000a ). Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J. Biol. Chem., 275, 19000 – 19008.en_US
dc.identifier.citedreferenceLIANG, M., ROSSER, M., NG, H. P., MAY, K., BAUMAN, J. G., ISLAM, I., GHANNAM, A., KRETSCHMER, P. J., PU, H., DUNNING, L., SNIDER, R. M., MORRISSEY, M. M., HESSELGESSER, J., PEREZ, H. D. & HORUK, R. ( 2000b ). Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. Eur. J. Pharmacol., 389, 41 – 49.en_US
dc.identifier.citedreferenceLLOYD, C. M. & RANKIN, S. M. ( 2003 ). Chemokines in allergic airway disease. Curr. Opin. Pharmacol., 3, 443 – 448.en_US
dc.identifier.citedreferenceMAMBULA, S. S., SAU, K., HENNEKE, P., GOLENBOCK, D. T. & LEVITZ, S. M. ( 2002 ). Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem., 277, 39320 – 39326.en_US
dc.identifier.citedreferenceMEHRAD, B., STRIETER, R. M., MOORE, T. A., TSAI, W. C., LIRA, S. A. & STANDIFORD, T. J. ( 1999 ). CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol., 163, 6086 – 6094.en_US
dc.identifier.citedreferenceMEHRAD, B., WIEKOWSKI, M., MORRISON, B. E., CHEN, S. C., CORONEL, E. C., MANFRA, D. J. & LIRA, S. A. ( 2002 ). Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am. J. Respir. Crit. Care Med., 166, 1263 – 1268.en_US
dc.identifier.citedreferenceMEIER, A., KIRSCHNING, C. J., NIKOLAUS, T., WAGNER, H., HEESEMANN, J. & EBEL, F. ( 2003 ). Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol., 5, 561 – 570.en_US
dc.identifier.citedreferenceNAGASE, H., MIYAMASU, M., YAMAGUCHI, M., FUJISAWA, T., KAWASAKI, H., OHTA, K., YAMAMOTO, K., MORITA, Y. & HIRAI, K. ( 2001 ). Regulation of chemokine receptor expression in eosinophils. Int. Arch. Allergy Immunol., 125 ( Suppl 1 ), 29 – 32.en_US
dc.identifier.citedreferenceNESS, T. L., HOGABOAM, C. M., STRIETER, R. M. & KUNKEL, S. L. ( 2003 ). Immunomodulatory role of CXCR2 during experimental septic peritonitis. J. Immunol., 171, 3775 – 3784.en_US
dc.identifier.citedreferenceNG, H. P., MAY, K., BAUMAN, J. G., GHANNAM, A., ISLAM, I., LIANG, M., HORUK, R., HESSELGESSER, J., SNIDER, R. M., PEREZ, H. D. & MORRISSEY, M. M. ( 1999 ). Discovery of novel non-peptide CCR1 receptor antagonists. J. Med. Chem., 42, 4680 – 4694.en_US
dc.identifier.citedreferenceOWEN, C. ( 2001 ). Chemokine receptors in airway disease: which receptors to target ? Pulm. Pharmacol. Ther., 14, 193 – 202.en_US
dc.identifier.citedreferencePHILIPPE, B., IBRAHIM-GRANET, O., PREVOST, M. C., GOUGEROT-POCIDALO, M. A., SANCHEZ PEREZ, M., VAN DER MEEREN, A. & LATGE, J. P. ( 2003 ). Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect. Immun., 71, 3034 – 3042.en_US
dc.identifier.citedreferencePOWER, C. A. & PROUDFOOT, A. E. ( 2001 ). The chemokine system: novel broad-spectrum therapeutic targets. Curr. Opin. Pharmacol., 1, 417 – 424.en_US
dc.identifier.citedreferencePROUDFOOT, A. E., POWER, C. A., ROMMEL, C. & WELLS, T. N. ( 2003 ). Strategies for chemokine antagonists as therapeutics. Semin. Immunol., 15, 57 – 65.en_US
dc.identifier.citedreferenceREDECKE, V., HACKER, H., DATTA, S. K., FERMIN, A., PITHA, P. M., BROIDE, D. H. & RAZ, E. ( 2004 ). Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol., 172, 2739 – 2743.en_US
dc.identifier.citedreferenceROMAGNANI, S. ( 2002 ). Cytokines and chemoattractants in allergic inflammation. Mol. Immunol., 38, 881 – 885.en_US
dc.identifier.citedreferenceSABROE, I., PECK, M. J., VAN KEULEN, B. J., JORRITSMA, A., SIMMONS, G., CLAPHAM, P. R., WILLIAMS, T. J. & PEASE, J. E. ( 2000 ). A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J. Biol. Chem., 275, 25892 – 25985.en_US
dc.identifier.citedreferenceSCHUH, J. M., BLEASE, K., BRUHL, H., MACK, M. & HOGABOAM, C. M. ( 2003a ). Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma. Eur. J. Immunol., 33, 3080 – 3090.en_US
dc.identifier.citedreferenceSCHUH, J. M., BLEASE, K. & HOGABOAM, C. M. ( 2002a ). The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J., 16, 228 – 230.en_US
dc.identifier.citedreferenceSCHUH, J. M., BLEASE, K., KUNKEL, S. L. & HOGABOAM, C. M. ( 2003b ). Chemokines and cytokines: axis and allies in asthma and allergy. Cytokine Growth Factor Rev., 14, 503 – 510.en_US
dc.identifier.citedreferenceSCHUH, J. M., POWER, C. A., PROUDFOOT, A. E., KUNKEL, S. L., LUKACS, N. W. & HOGABOAM, C. M. ( 2002b ). Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4−/− mice. FASEB J., 16, 1313 – 1315.en_US
dc.identifier.citedreferenceSTEVENS, D. A., MOSS, R. B., KURUP, V. P., KNUTSEN, A. P., GREENBERGER, P., JUDSON, M. A., DENNING, D. W., CRAMERI, R., BRODY, A. S., LIGHT, M., SKOV, M., MAISH, W. & MASTELLA, G. ( 2003 ). Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis., 37 ( Suppl 3 ), S225 – S264.en_US
dc.identifier.citedreferenceTAKEUCHI, O., KAWAI, T., SANJO, H., COPELAND, N. G., GILBERT, D. J., JENKINS, N. A., TAKEDA, K. & AKIRA, S. ( 1999 ). TLR6: a novel member of an expanding toll-like receptor family. Gene, 231, 59 – 65.en_US
dc.identifier.citedreferenceZIMMERMANN, N., HOGAN, S. P., MISHRA, A., BRANDT, E. B., BODETTE, T. R., POPE, S. M., FINKELMAN, F. D. & ROTHENBERG, M. E. ( 2000 ). Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J. Immunol., 165, 5839 – 5846.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sj.bjp.0706243.pdf
Size:
620.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.